𝔖 Bobbio Scriptorium

✦ LIBER ✦

524 Cisplatin (C) + ifosfamide (I) for patients with ovarian carcinoma (O.C.) with prior carboplatin (CBT) + cyclophosphamide (CTX) chemotherapy

✍ Scribed by A. Polyzos; L. Giannikos; M. Veslemes; N. Kalahanis; A. Gianopoulos; K. Giannakopoulos; K. Christodoulou

Book ID: 116167277
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 146 KB
Volume: 31
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(95)95778-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

8049 Cisplatin-based combination chemoth

8049 Cisplatin-based combination chemotherapy (CTX) consisting of docetaxel and cisplatin (DP) is still effective for patients with relapsed ovarian carcinoma (ROC) resistant or refractory to carboplatin-based CTX (TC: taxol/carboplatin)

✍ Shimizu, Y.; Murakami, F.; Saitoh, N.; Yamasaki, A.; Ogawa, N.; Ishiya, T.; Kata 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Long-term results of first-line sequenti

Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group: Schmoll HJ, Kollmannsberger C, Metzner B, Hartmann JT, Schleucher N, Schoffski P, Schleicher J, Rick O, Beyer J, Hossfeld D, Kanz L, Berdel WE, Andreesen R, Bokemeyer C, German Testicular Cancer Study Group, Department of Hematology/Oncology, University of Halle, Halle, Germany.

✍ Jerome P Richie 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 18 KB